Janus Henderson Group PLC Acquires 34,459 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Janus Henderson Group PLC boosted its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 16.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 248,540 shares of the company's stock after buying an additional 34,459 shares during the quarter. Janus Henderson Group PLC owned approximately 0.15% of Option Care Health worth $5,765,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in Option Care Health by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock valued at $448,118,000 after purchasing an additional 75,313 shares during the period. Wellington Management Group LLP increased its position in Option Care Health by 84.6% during the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock valued at $425,143,000 after purchasing an additional 8,400,208 shares during the period. Dimensional Fund Advisors LP increased its position in Option Care Health by 17.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock valued at $92,518,000 after purchasing an additional 591,042 shares during the period. Northern Trust Corp increased its position in Option Care Health by 11.8% during the 4th quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock valued at $60,934,000 after purchasing an additional 278,158 shares during the period. Finally, Norges Bank purchased a new position in Option Care Health during the 4th quarter valued at $60,219,000. 98.05% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.64% of the company's stock.

Option Care Health Stock Down 2.0%

OPCH stock traded down $0.64 during trading on Friday, hitting $31.39. 322,026 shares of the stock traded hands, compared to its average volume of 1,853,694. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The firm's 50 day moving average is $33.05 and its two-hundred day moving average is $29.24. The stock has a market cap of $5.14 billion, a price-to-earnings ratio of 26.42, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.36 by $0.04. The company had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. Option Care Health's revenue for the quarter was up 16.3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.26 EPS. On average, sell-side analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current year.

Analyst Ratings Changes

OPCH has been the topic of a number of research analyst reports. JPMorgan Chase & Co. boosted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and upped their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Barrington Research reaffirmed an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research report on Wednesday, April 30th. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. Finally, JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a research report on Tuesday, April 22nd. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, Option Care Health presently has an average rating of "Moderate Buy" and an average target price of $35.50.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.